PTEN loss in glioma cell lines leads to increased extracellular vesicle biogenesis and PD-L1 cargo in a PI3K-dependent manner
Journal of Biological Chemistry · 2025-02 · 301 (2) · 108143
DOI: 10.1016/j.jbc.2024.108143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-02. Verfasst von Julio C Sanchez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, B7-H1 Antigen, Extracellular Vesicles, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Phosphatase and Tensin Homolog (PTEN) is one of the most frequently lost tumor suppressors in cancer and the predominant negative regulator of the PI3K-AKT signaling axis. A growing body of evidence has highlighted the loss of PTEN with immuno-modulatory functions including the upregulation of the programmed death ligand-1 (PD-L1), an altered tumor-derived secretome that drives an immunosuppressive tumor immune microenvironment and resistance to certain immunotherapies. Given their roles in immunosuppression and tumor growth, we examined whether the loss of PTEN would impact the biogenesis, cargo, and function of extracellular vesicles (EVs) in the context of the anti-tumor associated cytokine interferon-γ. Through genetic and pharmacological approaches, we show that total cellular expression of PD-L1 is regulated by JAK/STAT signaling, not PI3K signaling. Instead, we observe that PTEN loss specifically upregulates cell surface levels of PD-L1 and enhances the biogenesis of EVs enriched with PD-L1 in a PI3K-dependent manner. We demonstrate that because of these changes, EVs derived from glioma cells lacking PTEN have a greater ability to suppress T cell receptor signaling. Taken together, these findings provide important new insights into how the loss of PTEN can contribute to an immunosuppressive tumor immune microenvironment, facilitate immune evasion, and highlight a novel role for PI3K signaling in the regulation of EV biogenesis and the cargo they contain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
- Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
- Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York, USA. Electronic address: R…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Science Foundation
- National Institutes of Health
- Alfred P. Sloan Foundation
- National Institutes of Health National Cancer Institute
Zitieren
APA
Sanchez, J. C., Pierpont, T. M., Argueta-Zamora, D., Wilson, K., August, A., & Cerione, R. A. (2025). PTEN loss in glioma cell lines leads to increased extracellular vesicle biogenesis and PD-L1 cargo in a PI3K-dependent manner. Journal of Biological Chemistry, 301(2), 108143. https://doi.org/10.1016/j.jbc.2024.108143
Vancouver
Sanchez JC, Pierpont TM, Argueta-Zamora D, Wilson K, August A, Cerione RA. PTEN loss in glioma cell lines leads to increased extracellular vesicle biogenesis and PD-L1 cargo in a PI3K-dependent manner. Journal of Biological Chemistry. 2025;301(2):108143. doi:10.1016/j.jbc.2024.108143
BibTeX
@article{Sanchez2025,
author = {Sanchez, Julio C and Pierpont, Timothy M and Argueta-Zamora, Dariana and Wilson, Kristin and August, Avery and Cerione, Richard A},
title = {PTEN loss in glioma cell lines leads to increased extracellular vesicle biogenesis and PD-L1 cargo in a PI3K-dependent manner},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {2},
pages = {108143},
doi = {10.1016/j.jbc.2024.108143}
}
EUVIMED